Aramark (ARMK) Director Records 111.956 Dividend Equivalent Shares

Rhea-AI Filing Summary

Susan M. Cameron, a director of Aramark (ARMK), reported a non‑derivative acquisition of 111.956 shares on 08/20/2025. The filing states these shares represent dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. The reported per‑share price is $0, and following the transaction the reporting person beneficially owns 42,825.523 shares. The Form 4 was signed by an attorney‑in‑fact on 08/21/2025.

Positive

• Transparent disclosure of director compensation through dividend equivalent rights
• Beneficial ownership updated to reflect accrued awards: 42,825.523 shares

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine acquisition of dividend equivalents; likely administrative and not a material ownership change.

This Form 4 documents a grant of 111.956 dividend equivalent shares to Susan M. Cameron tied to deferred stock units, recorded at a $0 price because they reflect accrued dividends rather than cash purchases. The resulting beneficial ownership of 42,825.523 shares should be compared to total outstanding shares (not provided) to assess materiality; based solely on this filing, the transaction appears administrative and routine for a director compensation program.

Corporate Governance Expert

TL;DR: Transaction aligns with typical director compensation practices; no unusual timing or exercise terms disclosed.

The disclosure identifies the instruments as dividend equivalent rights that vest on the same schedule as underlying awards, which is consistent with deferred compensation governance. The record shows the acquisition date of 08/20/2025 and a $0 price, indicating these are non‑purchased credits. From a governance perspective, the filing provides necessary transparency but contains no additional context about the underlying award schedules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAMERON SUSAN M.

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		111.956(1)	A	$0	42,825.523	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Susan M. Cameron report on the Form 4 for ARMK?

She reported an acquisition of 111.956 shares as dividend equivalent rights on 08/20/2025, bringing her beneficial ownership to 42,825.523 shares.

Why is the price listed as $0 on the Form 4?

The filing states these are dividend equivalent rights accrued on deferred stock units, which are recorded at a $0 purchase price because they reflect credited dividends rather than a cash purchase.

What is the nature of the reported securities?

They are non‑derivative common stock shares representing dividend equivalents that vest on the same schedule as the underlying deferred awards.

When was the Form 4 signed and filed?

The signature on the form was made by an attorney‑in‑fact on 08/21/2025 following the 08/20/2025 transaction date.